MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo.
Saved in:
| Title: | MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo. |
|---|---|
| Authors: | Walter K; Department of Internal Medicine I, Ulm University, Germany., Tiwary K; Department of Internal Medicine I, Ulm University, Germany., Trajkovic-Arsic M; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hidalgo-Sastre A; Klinik und Poliklinik für Innere Medizin II, Technical University Munich, Germany., Dierichs L; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Liffers ST; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Gu J; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Gout J; Department of Internal Medicine I, Ulm University, Germany., Schulte LA; Department of Internal Medicine I, Ulm University, Germany., Münch J; Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany., Seufferlein T; Department of Internal Medicine I, Ulm University, Germany., Sainz B Jr; Department of Biochemistry, Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Department of Cancer Biology, Instituto de Investigaciones Biomédicas 'Alberto Sols' (IIBM), CSIC-UAM, Madrid, Spain.; Chronic Diseases and Cancer, Area 3-Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Siveke JT; Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.; German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Rodriguez-Aznar E; Department of Internal Medicine I, Ulm University, Germany., Hermann PC; Department of Internal Medicine I, Ulm University, Germany. |
| Source: | Stem cells international [Stem Cells Int] 2019 Jun 02; Vol. 2019, pp. 8475389. Date of Electronic Publication: 2019 Jun 02 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101535822 Publication Model: eCollection Cited Medium: Print ISSN: 1687-966X (Print) NLM ISO Abbreviation: Stem Cells Int Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
